Biotech
Israeli health-tech conference opens in Jerusalem with 1,800 participants from 40 countries
MIXiii Health-Tech.IL 2026 brought together investors, doctors, researchers, startups and global health-tech leaders, with a focus on Israeli emergency medicine, tech-bio, and technologies.
Israeli life sciences investments fell 40% in 2025, report found
Startup wants to grow “headless humans” to replace lab animals
Israeli mathematician uses AI to decode human immune system
New at-home brain monitoring solution launched by X-trodes, Emotiv
The collaboration pairs X-trodes’ wearable sensing technology with EmotivPRO, EMOTIV’s EEG data platform for neuroscience research.
Israeli breakthrough company seeks to use cells to improve quality of life
The biotechnology company Pluri, is expanding its activities and establishing strategic collaborations for the development and marketing of food-tech and pharmaceutical products.
EU regulator backs two Omicron-adapted COVID boosters
Developed by Moderna and the team of Pfizer and BioNTech, the new so-called bivalent shots combat the BA.1 version of Omicron and the original virus first detected in China.
How do you make it to the top? Three female leaders give their best advice
What are three mottos you should swear by, according to three of the biggest biotechnological leaders in Israel?
CRISPR gene editing may cause permanent damage - study
Caution from researchers at Tel Aviv University: CRISPR gene editing can damage the genome and might trigger cancer.
Precise Bio partners with ZEISS to develop bio-printed cornea implants
These bio-printed eye tissues would be used for transplants to treat vision correction and corneal diseases such as keratoconus.
BioGenCell raises $16m. for chronic disease treatment
The company’s treatment has already prevented loss of limb in several patients during Phase I trials.
AI bio-tech company Nucleai raises $33M, brings in new executives
Nuclei aims to use the funds to further its efforts to transform drug development and clinical treatments.
Israeli Biotech company says it can revolutionize drug development
Tissue Dynamics Ltd., an Israeli biotechnology company, says it can cut drug development cost by 40% to 80% and the time required by 30% to 50%.
‘Cell-based, innovative products for a better future’
Pluristem’s proprietary cell-based technology platform develops cutting-edge therapies and cultured food materials
